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Joel N. Hirschhorn2,3,4,*My name is Joel Hirschhorn, and it is my great pleasure to
introduce my parents, Kurt and Rochelle Hirschhorn, re-
cipients of the 2013 Victor A. McKusick Leadership Award.
I have none of the usual conflicts of interest, but I do note
that I received from the recipients extensive financial and
emotional support, as well as life itself.
Often, these introductions are done by a current or
former trainee. I was not my parents’ first trainee, but I
was certainly one of the youngest—the joke around the
house is that some of my first words were ‘‘adenosine
deaminase deficiency.’’
As many of you know, my parents enjoy talking about
the achievements of their children and grandchildren
but are not as eager to brag about themselves. So, I will
do my best to brag on their behalf.
This is a joint award, and in addition to beingmarried for
over 60 years, my parents have been occasional formal
collaborators. A review of their CVs shows that they have
copublished papers or chapters in five of the last seven de-
cades; their scientific collaboration in the field of human
genetics began in Sweden in 1957, resulting in their first
joint paper in Science. Of course, they have much more
frequently been informal collaborators with a constant
back-and-forth flow of ideas, as I witnessed over the dinner
table and asmany of you have witnessed at these and other
meetings that they have attended together, such as shown
here. They have both been members and regular attendees
at meetings of The American Society of Human Genetics
(ASHG) for over 40 years.
This award is named for Victor A. McKusick. Unlike my
parents, I did not get the chance to know him, but I do
know that his name is synonymous with leadership in
many aspects of human genetics and that his impressive
legacy remains strong today. Rochelle and Kurt have each
been leaders in multiple ways: not only in scientific
achievement but also in other significant respects. These
include leadership roles in many scientific societies,
including ASHG, in leading by example, in pointing out
or helping establish new directions for the field of human
genetics, and even in being willing to speak out occasion-
ally, or sometimes more than occasionally, about impor-
tant issues of the day.1This article is based on the address given by the author at themeeting of The A
MA, USA. The audio of the original address can be found at the ASHG website
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refugee from the Nazis in 1938, and he eventually made
his way 2 years later to Pittsburgh, where he enrolled in
the University of Pittsburgh. After he served in the Army
during and after World War II, his family moved to New
York and he finished college at New York University
(NYU). He graduated from NYU Medical School in 1954.
Rochelle’s journey was at least geographically shorter: she
grew up in Depression-era Brooklyn and then moved to
Manhattan, where she graduated from Barnard College
in 1953 and from NYU Medical School in 1957.
Rochelle has made a number of seminal scientific contri-
butions, particularly in the fields of immunodeficiencies
and lysosomal-storage disorders. She discovered the genetic
structure of the adenosine deaminase (ADA)-encoding
gene,which ismutated in a formof severe combined immu-
nodeficiency, and of the acid-alpha-glucosidase-encoding
gene, which is mutated in Pompe disease. She identified
and characterized numerous mutations of varying severity
in these genes and became an international resource for
clinicians treating patients with ADA deficiency. Through
careful studies of patients with ADA deficiency, she discov-
ered the key role of deoxyATP in the pathophysiology. She
also recognized and described the first example of somatic
reversion of a disease-causing mutation in two patients, re-
sulting in a resolution of their disease. Because of this and
other observations, she correctly predicted that ADA defi-
ciency would lead the way as a target for gene therapy.
Using red cell transfusions, Rochelle also provided the first
evidence that enzyme-replacement therapy would be suc-
cessful in ameliorating ADA deficiency.
This body of work has been recognized in a variety of
ways. These include being honored as a recipient of the
Berson Award and Master Scientist Award from NYU
(where she was chief of the Division of Medical Genetics
for 24 years), being elected to the Institutes of Medicine
and other prestigious societies, and receiving the 2003
Distinguished Alumna Award from her alma mater, Bar-
nard College.
Rochelle has led not only by scientific achievement but
also by example as a female physician-scientist in an era
when there were few such role models and when theremerican Society of HumanGenetics (ASHG) onOctober 26, 2013, in Boston,
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was frequent and active opposition to the idea that a
woman could or should pursue such a career. When, in
1986, she was elected to the Interurban Clinical Club,
founded in 1905 by William Osler, she was its first female
member; she shortly thereafter became its first female pres-
ident. She also had a variety of significant roles in ASHG
throughout her career, serving as a visible role model for
young geneticists. She has also paid special attention to
mentoring female scientists throughout her career.
Kurt has also had numerous scientific achievements,
beginning notably with signature accomplishments in
two different fields. In immunology, he and colleagues
described the mixed lymphocyte reaction, which is the ba-
sis for human leukocyte antigen matching in transplanta-
tion. In human genetics, he was the first to describe, in
1961, a partial deletion of a chromosome in 4p syndrome
(also known as Wolf-Hirschhorn syndrome). This discov-
ery was the beginning of an early and sustained use of
cytogenetics to identify a wide variety of chromosomal dis-
orders; such an approach is the foundation of prenatal and
genetic diagnosis as it is still practiced today.
Beyond his scientific achievements, Kurt played a major
leadership role in advancing the field of human genetics.
In 1968, he founded one of the first Divisions of Medical
Genetics at Mount Sinai School of Medicine. In 1977, he
became the chairman of the Department of Pediatrics at
Mount Sinai, where during his 18 years in that role he
continued to stress the importance of genetics in research
and in the clinical care of children. Within ASHG, he has
been a member and meeting attendee since 1958, served
two separate stints on the Board of Directors, was the soci-The Ameety president in 1969, and chaired the Awards Committee.
Outside of ASHG, Kurt was one of the founders of the
American College of Medical Genetics and was also instru-
mental in helping establish the first Masters-level genetic-
counseling program at Sarah Lawrence. He was one of the
founders of the Hastings Center (also called the Institute
for Society, Ethics, and the Life Sciences) and served on
the ethics committee at Mount Sinai for 30 years. With
Harry Harris, who was a mentor and colleague to both
Kurt and Rochelle, he edited the first 25 volumes of the
Advances in Human Genetics.
Kurt’s leadership and scientific career have been recog-
nized by a wide variety of awards, including the William
Allan Award and Award for Excellence in Human Genetics
Education from ASHG, election to the Institute of Medi-
cine, the Colonel Sanders Lifetime Achievement Award
from theMarch of Dimes, and the Howland Award in Pedi-
atrics. Like Rochelle, he has a strong commitment to teach-
ing and mentoring (they have both taught their medical
school’s human genetics course). Even now, Kurt spends
much of his day giving advice to trainees and faculty
alike—and those of you who know my father know how
much he enjoys giving advice.
In Yiddish, to have ‘‘naches’’ means to have pride and
joy in the achievements of others, usually one’s children.
Today, my sisters, Melanie and Lisa, our families (Lisa, Ben-
nett, Jane, and Ariel are here also), and I have ‘‘reverse
naches’’—we are proud and happy for the achievements
of our parents. And on that note, I present Drs. Rochelle
and Kurt Hirschhorn, recipients of the 2013 Victor A.
McKusick Leadership Award.rican Journal of Human Genetics 94, 334–335, March 6, 2014 335
